Blood test could revolutionize how doctors track testicular cancer
NCT ID NCT07376096
Summary
This study aims to see if a 'liquid biopsy' blood test can detect and monitor testicular germ cell tumors. Researchers will enroll 200 men—100 with early-stage cancer and 100 with cancer that has spread—and collect their blood at key points during treatment. The goal is to compare this new blood test to current monitoring methods to see if it's more accurate, especially for patients whose cancer doesn't show up on standard tests.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for 100 STAGE I PATIENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.